Gary Reuther, PhD (Professor in the Departments of Molecular Oncology and Malignant Hematology at the Moffitt Cancer Center) earned his PhD from Duke University and did his post-doctoral training with Channing Der (University of North Carolina at Chapel Hill), where he studied signaling by the RAS oncoprotein and identified novel leukemia oncogenes. His current research centers on JAK2 signaling and novel therapeutic strategies for MPNs. Over the past 20 years, he has obtained research funding from multiple NIH R01 grants, the MPN Research Foundation, the Leukemia and Lymphoma Society, the Department of Defense, and the V Foundation for Cancer Research, and was the recipient of an American Cancer Society Research Scholar Award and an NIH/NCI Howard Temin Award. His experience leading research that led to this funding and successful completion and publication of these projects makes him highly qualified to serve as the PI on the proposed studies.

Gary Reuther PhD
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida
United States
Project Title
Novel therapeutic strategies to improve the outcomes of patients with myeloproliferative neoplasms
Program
Translational Research Program